Search Results for "treatment guidelines"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for treatment guidelines. Results 161 to 169 of 169 total matches.
Opioids for Pain
The Medical Letter on Drugs and Therapeutics • Dec 12, 2022 (Issue 1665)
Opioids for Pain
A new CDC guideline for prescribing opioids for pain
recently became available.1 ...
A new CDC guideline for prescribing opioids for pain
recently became available. Nonopioid drugs for pain
were reviewed in a previous issue.
Insect Repellents
The Medical Letter on Drugs and Therapeutics • Jul 07, 2025 (Issue 1732)
)
HOMS Bite Blocker BioUD Insect Repellent
and Clothing Treatment
7.75% pump spray 5 hours ▶ Repels ...
The Centers for Disease Control and Prevention
(CDC) and the Environmental Protection Agency (EPA)
recommend using insect repellents to avoid being
bitten by mosquitoes, ticks, and other arthropods
that transmit disease-causing pathogens. Repellents
applied to exposed skin should be used in conjunction
with other preventive measures such as wearing long-sleeved
shirts, pants, and socks and avoiding outdoor
activities during peak mosquito-biting times. Some
insect repellents are listed in Table 1.
Med Lett Drugs Ther. 2025 Jul 7;67(1732):105-9 doi:10.58347/tml.2025.1732a | Show Introduction Hide Introduction
Drugs for Dementia
The Medical Letter on Drugs and Therapeutics • Mar 30, 2026 (Issue 1751)
are FDA-approved for treatment of
AD dementia. Rivastigmine is also approved for
treatment of dementia ...
Alzheimer's disease (AD) is the most common cause
of dementia, but cognitive decline also occurs in
other neurological conditions, such as Parkinson's
disease, Lewy body dementia, vascular dementia, and
frontotemporal dementia.
Med Lett Drugs Ther. 2026 Mar 30;68(1751):49-56 doi:10.58347/tml.2026.1751a | Show Introduction Hide Introduction
Drugs for Anxiety Disorders
The Medical Letter on Drugs and Therapeutics • Aug 07, 2023 (Issue 1682)
classes are used for treatment of anxiety
disorders, but only a small number of randomized
comparative ...
Anxiety disorders (generalized anxiety disorder,
panic disorder, social anxiety disorder, and various
phobias) are the most common form of psychiatric
illness. They can be treated effectively with cognitive
behavioral therapy (CBT) and/or pharmacotherapy.
Med Lett Drugs Ther. 2023 Aug 7;65(1682):121-8 doi:10.58347/tml.2023.1682a | Show Introduction Hide Introduction
Nonopioid Drugs for Pain
The Medical Letter on Drugs and Therapeutics • Mar 07, 2022 (Issue 1645)
Nonopioid Drugs for Pain
Nonopioid drugs can be used in the treatment of
many nociceptive ...
Nonopioid drugs can be used in the treatment of
many nociceptive and neuropathic pain conditions.
For severe pain, especially severe chronic cancer
pain, use of opioids may be necessary. Noninvasive
nonpharmacologic treatments, including physical
and psychological therapies, have been shown to
improve pain and function in patients with some
common chronic pain conditions and are unlikely
to cause serious harms. A multimodal approach to
analgesic therapy can increase pain control while
reducing opioid use and adverse effects.
Drugs for ADHD
The Medical Letter on Drugs and Therapeutics • Sep 01, 2025 (Issue 1736)
persists into adulthood.1 Pharmacologic treatment
of ADHD has been associated with reduced risks ...
Attention-deficit/hyperactivity disorder (ADHD) is a
common chronic neurodevelopmental disorder often
diagnosed in school-age children that frequently
persists into adulthood.Pharmacologic treatment
of ADHD has been associated with reduced risks of
substance abuse, criminal behavior, unintentional
injuries, serious traffic accidents, and all-cause
mortality. Drugs approved by the FDA for treatment
of ADHD are listed in Table 1.
Med Lett Drugs Ther. 2025 Sep 1;67(1736):137-44 doi:10.58347/tml.2025.1736a | Show Introduction Hide Introduction
Adult Immunization
The Medical Letter on Drugs and Therapeutics • Aug 17, 2026 (Issue 1761)
. Guidelines from the Infectious Diseases
Society of America and the American Medical Association
recommend ...
The CDC Advisory Committee on Immunization Practices
(ACIP) recommends certain vaccines for adults residing in
the US. The American Academy of Family Physicians has
also recently published an adult immunization schedule.
Recommendations for vaccination against COVID-19 and
seasonal influenza will be reviewed separately.
Med Lett Drugs Ther. 2026 Aug 17;68(1761):129-35 doi:10.58347/tml.2026.1761a | Show Introduction Hide Introduction
Drugs for Epilepsy
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024 (Issue 1708)
with childbearing potential, and cost. Treatment should begin with a single drug, increasing the dosage gradually ...
When used for the appropriate seizure type,
antiseizure medications (ASMs) are roughly
equivalent in efficacy. In addition to the seizure type,
the choice of drug is usually based on factors such
as ease of use, spectrum of activity, adverse effects,
interactions with other drugs, presence of comorbid
conditions, suitability for elderly persons and those
with childbearing potential, and cost. Treatment
should begin with a single drug, increasing the
dosage gradually until seizures are controlled or
adverse effects become unacceptable. If seizures
persist, expert clinicians generally...
Med Lett Drugs Ther. 2024 Aug 5;66(1708):121-8 doi:10.58347/tml.2024.1708a | Show Introduction Hide Introduction
Seasonal Influenza Vaccination: 2026-2027
The Medical Letter on Drugs and Therapeutics • Oct 12, 2026 (Issue 1765)
in pregnancy: prevention and treatment. Practice
Advisory August 2025. Available at: https://bit.ly/4yQeyGq ...
Annual influenza vaccination is recommended for all persons
≥6 months old without a contraindication. Influenza
vaccines available this season in the US are listed in Table 3.
Med Lett Drugs Ther. 2026 Oct 12;68(1765):161-7 doi:10.58347/tml.2026.1765a | Show Introduction Hide Introduction
